These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. McMillan JR; McGrath JA; Pulkkinen L; Kon A; Burgeson RE; Ortonne JP; Meneguzzi G; Uitto J; Eady RA Br J Dermatol; 1997 Jun; 136(6):817-22. PubMed ID: 9217810 [TBL] [Abstract][Full Text] [Related]
44. Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm. Condorelli AG; Fortugno P; Cianfarani F; Proto V; Di Zenzo G; Didona B; Zambruno G; Castiglia D Br J Dermatol; 2018 Jun; 178(6):1416-1422. PubMed ID: 28561256 [TBL] [Abstract][Full Text] [Related]
45. A missense mutation (G1506E) in the adhesion G domain of laminin-5 causes mild junctional epidermolysis bullosa. Scaturro M; Posteraro P; Mastrogiacomo A; Zaccaria ML; De Luca N; Mazzanti C; Zambruno G; Castiglia D Biochem Biophys Res Commun; 2003 Sep; 309(1):96-103. PubMed ID: 12943669 [TBL] [Abstract][Full Text] [Related]
46. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa. Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767 [TBL] [Abstract][Full Text] [Related]
47. Hemidesmosome assembly assessed by expression of a wild-type integrin beta 4 cDNA in junctional epidermolysis bullosa keratinocytes. Gagnoux-Palacios L; Gache Y; Ortonne JP; Meneguzzi G Lab Invest; 1997 Nov; 77(5):459-68. PubMed ID: 9389789 [TBL] [Abstract][Full Text] [Related]
55. Laminin 332 in junctional epidermolysis bullosa. Kiritsi D; Has C; Bruckner-Tuderman L Cell Adh Migr; 2013; 7(1):135-41. PubMed ID: 23076207 [TBL] [Abstract][Full Text] [Related]
56. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Gache Y; Allegra M; Bodemer C; Pisani-Spadafora A; de Prost Y; Ortonne JP; Meneguzzi G Hum Mol Genet; 2001 Oct; 10(21):2453-61. PubMed ID: 11689492 [TBL] [Abstract][Full Text] [Related]
57. [Differences in the character of interaction of normal and transformed human keratinocytes with laminin isoforms]. Cherepanova OA; Kalmykova NV; Koronkina IV; Aré AF; Gorelik IuV; Pinaev GP Tsitologiia; 2002; 44(2):151-8. PubMed ID: 12053765 [TBL] [Abstract][Full Text] [Related]
58. Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro. Igoucheva O; Kelly A; Uitto J; Alexeev V J Invest Dermatol; 2008 Jun; 128(6):1476-86. PubMed ID: 18079746 [TBL] [Abstract][Full Text] [Related]
59. Biological function of laminin-5 and pathogenic impact of its deficiency. Schneider H; Mühle C; Pacho F Eur J Cell Biol; 2007 Dec; 86(11-12):701-17. PubMed ID: 17000025 [TBL] [Abstract][Full Text] [Related]
60. Extent of laminin-5 assembly and secretion effect junctional epidermolysis bullosa phenotype. Matsui C; Pereira P; Wang CK; Nelson CF; Kutzkey T; Lanigan C; Woodley D; Morohashi M; Welsh EA; Hoeffler WK J Exp Med; 1998 Apr; 187(8):1273-83. PubMed ID: 9547338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]